211 related articles for article (PubMed ID: 36466839)
1. Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage.
Erdmann N; Schilling T; Hentschel J; Lehmann T; von Bismarck P; Ankermann T; Duckstein F; Baier M; Zagoya C; Mainz JG
Front Immunol; 2022; 13():947359. PubMed ID: 36466839
[TBL] [Abstract][Full Text] [Related]
2. Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.
Janhsen WK; Arnold C; Hentschel J; Lehmann T; Pfister W; Baier M; Böer K; Hünniger K; Kurzai O; Hipler UC; Mainz JG
Med Microbiol Immunol; 2016 Oct; 205(5):485-500. PubMed ID: 27377929
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive assessment of upper and lower airway infection and inflammation in CF patients.
Fischer N; Hentschel J; Markert UR; Keller PM; Pletz MW; Mainz JG
Pediatr Pulmonol; 2014 Nov; 49(11):1065-75. PubMed ID: 24464968
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment.
Hentschel J; Jäger M; Beiersdorf N; Fischer N; Doht F; Michl RK; Lehmann T; Markert UR; Böer K; Keller PM; Pletz MW; Mainz JG
BMC Pulm Med; 2014 May; 14():82. PubMed ID: 24885494
[TBL] [Abstract][Full Text] [Related]
5. Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients.
Mauch RM; Hentschel J; Aanaes K; Barucha A; Nolasco da Silva MT; Levy CE; Høiby N; Mainz JG
Pediatr Pulmonol; 2020 Apr; 55(4):959-967. PubMed ID: 32022432
[TBL] [Abstract][Full Text] [Related]
6. Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy.
Müller U; Hentschel J; Janhsen WK; Hünniger K; Hipler UC; Sonnemann J; Pfister W; Böer K; Lehmann T; Mainz JG
Mediators Inflamm; 2015; 2015():626530. PubMed ID: 26185365
[TBL] [Abstract][Full Text] [Related]
7. Ivacaftor Reduces Inflammatory Mediators in Upper Airway Lining Fluid From Cystic Fibrosis Patients With a G551D Mutation: Serial Non-Invasive Home-Based Collection of Upper Airway Lining Fluid.
Mainz JG; Arnold C; Wittstock K; Hipler UC; Lehmann T; Zagoya C; Duckstein F; Ellemunter H; Hentschel J
Front Immunol; 2021; 12():642180. PubMed ID: 34025651
[TBL] [Abstract][Full Text] [Related]
8. Increased cytokines in cystic fibrosis patients' upper airways during a new P. aeruginosa colonization.
Jaudszus A; Arnold C; Hentschel J; Hünniger K; Baier M; Mainz JG
Pediatr Pulmonol; 2018 Jul; 53(7):881-887. PubMed ID: 29624919
[TBL] [Abstract][Full Text] [Related]
9. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
10. Nasal lavage microbiome, but not nasal swab microbiome, correlates with sinonasal inflammation in children with cystic fibrosis.
Chung J; Boutin S; Frey DL; Joachim C; Mall MA; Sommerburg O
J Cyst Fibros; 2024 Mar; 23(2):226-233. PubMed ID: 38199892
[TBL] [Abstract][Full Text] [Related]
11. Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers--evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseases.
Hentschel J; Müller U; Doht F; Fischer N; Böer K; Sonnemann J; Hipler C; Hünniger K; Kurzai O; Markert UR; Mainz JG
J Immunol Methods; 2014 Feb; 404():41-51. PubMed ID: 24370751
[TBL] [Abstract][Full Text] [Related]
12. IP-10 is a potential biomarker of cystic fibrosis acute pulmonary exacerbations.
Solomon GM; Frederick C; Zhang S; Gaggar A; Harris T; Woodworth BA; Steele C; Rowe SM
PLoS One; 2013; 8(8):e72398. PubMed ID: 23977293
[TBL] [Abstract][Full Text] [Related]
13. Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis.
Henriksson G; Westrin KM; Karpati F; Wikström AC; Stierna P; Hjelte L
Chest; 2002 Jan; 121(1):40-7. PubMed ID: 11796430
[TBL] [Abstract][Full Text] [Related]
14. Nasal airway inflammatory responses and pathogen detection in infants with cystic fibrosis.
Kopp BT; Ross SE; Bojja D; Guglani L; Chandler JD; Tirouvanziam R; Thompson M; Slaven JE; Chmiel JF; Siracusa C; Sanders DB
J Cyst Fibros; 2024 Mar; 23(2):219-225. PubMed ID: 37977937
[TBL] [Abstract][Full Text] [Related]
15. The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial.
Stick SM; Foti A; Ware RS; Tiddens HAWM; Clements BS; Armstrong DS; Selvadurai H; Tai A; Cooper PJ; Byrnes CA; Belessis Y; Wainwright C; Jaffe A; Robinson P; Saiman L; Sly PD;
Lancet Respir Med; 2022 Aug; 10(8):776-784. PubMed ID: 35662406
[TBL] [Abstract][Full Text] [Related]
16. Long term azithromycin therapy in patients with cystic fibrosis.
Emiralioğlu N; Öztürk Z; Yalçın E; Doğru D; Özçelik U; Kiper N
Turk J Pediatr; 2016; 58(1):34-40. PubMed ID: 27922234
[TBL] [Abstract][Full Text] [Related]
17. Soluble inflammation markers in nasal lavage from CF patients and healthy controls.
Beiersdorf N; Schien M; Hentschel J; Pfister W; Markert UR; Mainz JG
J Cyst Fibros; 2013 May; 12(3):249-57. PubMed ID: 22990051
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections.
Bodini A; D'Orazio C; Peroni D; Corradi M; Folesani G; Baraldi E; Assael BM; Boner A; Piacentini GL
Pediatr Pulmonol; 2005 Dec; 40(6):494-9. PubMed ID: 16229003
[TBL] [Abstract][Full Text] [Related]
19. Detection of bile acids in bronchoalveolar lavage fluid defines the inflammatory and microbial landscape of the lower airways in infants with cystic fibrosis.
Caparrós-Martín JA; Saladie M; Agudelo-Romero SP; Reen FJ; Ware RS; Sly PD; Stick SM; O'Gara F;
Microbiome; 2023 Jun; 11(1):132. PubMed ID: 37312128
[TBL] [Abstract][Full Text] [Related]
20. Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6.
Majka G; Mazurek H; Strus M; Ciszek-Lenda M; Szatanek R; Pac A; Golińska E; Marcinkiewicz J
Clin Exp Immunol; 2021 Sep; 205(3):391-405. PubMed ID: 34031873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
